Multi-Omics Characterizes the Effects and Mechanisms of CD1d in Nonalcoholic Fatty Liver Disease Development

Effects of a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator, Pemafibrate, on Metabolic Parameters: A Retrospective Longitudinal Study

(2022) Hidekatsu Yanai et al.   Biomedicines

Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease

(2021) Soo Lim et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Nanocapsule-mediated sustained H2 release in the gut ameliorates metabolic dysfunction-associated fatty liver disease

(2021) Zhaokui Jin et al.   BIOMATERIALS

Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma

(2021) Feng Chen et al.   GUT

Fatty Acid Synthase–Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLD

(2021) Yufeng Hu et al.   HEPATOLOGY

Metabolic dysfunction associated fatty liver disease improves detection of high liver stiffness: The rotterdam study

(2021) Laurens van Kleef et al.   HEPATOLOGY

Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests

(2021) Mojgan Masoodi et al.   Nature Reviews Gastroenterology & Hepatology

Efficacy of Zhuyu Pill Intervention in a Cholestasis Rat Model: Mutual Effects on Fecal Metabolism and Microbial Diversity

(2021) Han Yu et al.   Frontiers in Pharmacology

NAFLD - A rising metabolic disease

(2021) Anja Zeigerer   Molecular Metabolism

Switch‐associated protein 70 protects against nonalcoholic fatty liver disease via suppression of TAK1

(2021) Qiaofeng Qian et al.   HEPATOLOGY

OTUB1 alleviates NASH through inhibition of the TRAF6‐ASK1 signaling pathways

(2021) Jie‐Lei Zhang et al.   HEPATOLOGY

Linking liver metabolic and vascular disease via bile acid signaling

(2021) Stefano Fiorucci et al.   TRENDS IN MOLECULAR MEDICINE

Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement

(2021) Mohammed Eslam et al.   Lancet Gastroenterology & Hepatology

ER stress in antigen‐presenting cells promotes NKT cell activation through endogenous neutral lipids

(2020) Srinath Govindarajan et al.   EMBO REPORTS

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

Structural Dynamics of the Lipid Antigen-Binding Site of CD1d Protein

(2020) Bruno Cuevas-Zuviría et al.   Biomolecules

MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD

(2020) Marica Meroni et al.   EBioMedicine

Deep longitudinal multiomics profiling reveals two biological seasonal patterns in California

(2020) M. Reza Sailani et al.   Nature Communications

Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD

(2020) Giljae Lee et al.   Nature Communications

CD1d1 intrinsic signaling in macrophages controls NLRP3 inflammasome expression during inflammation

(2020) Shan Cui et al.   Science Advances

Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome

(2020) Oren Rom et al.   Science Translational Medicine

Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression

(2020) Nisreen Nimer et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Unexpected Rapid Increase in the Burden of Nonalcoholic Fatty Liver Disease in China From 2008 to 2018: A Systematic Review and Meta‐Analysis

(2019) Feng Zhou et al.   HEPATOLOGY

γδT cells and CD1d, novel immune players in alcoholic and nonalcoholic steatohepatitis?

(2019) Xiaolin Wang et al.   HEPATOLOGY

Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors

(2019) Catarina F. Almeida et al.   Nature Communications

Non-alcoholic fatty liver disease

(2018) James Maurice et al.   CLINICAL MEDICINE

Mechanisms of NAFLD development and therapeutic strategies

(2018) Scott L. Friedman et al.   NATURE MEDICINE

Complex Network of NKT Cell Subsets Controls Immune Homeostasis in Liver and Gut

(2018) Idania Marrero et al.   Frontiers in Immunology

Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics

(2018) Jiezhong Chen et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis

(2018) Igor Maricic et al.   JOURNAL OF IMMUNOLOGY

Macrophage de novo NAD+ synthesis specifies immune function in aging and inflammation

(2018) Paras S. Minhas et al.   NATURE IMMUNOLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Natural killer T (NKT) cells in autoimmune hepatitis

(2013) Jochen Mattner   CURRENT OPINION IN IMMUNOLOGY

Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs

(2013) R. V. V. Tatituri et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells

(2012) Enrico Girardi et al.   IMMUNOLOGICAL REVIEWS

Invariant natural killer T cells as sensors and managers of inflammation

(2012) Luc Van Kaer et al.   TRENDS IN IMMUNOLOGY

New ways to turn on NKT cells: Figure 1.

(2011) Dale Ian Godfrey et al.   JOURNAL OF EXPERIMENTAL MEDICINE